Complement Inhibitors in Myasthenia Gravis
Dr Neelam Gupta highlights differences between recently approved complement inhibitors for treatment of myasthenia gravis.
Efgartigimod In Myasthenia Gravis
A neuromuscular disorder specialist, Dr Neelam Goyal shares data with efgartigimod, a neonatal Fc receptor inhibitor, for treatment of myasthenia gravis.
Targeting Different Mechanisms of Action to Treat Myasthenia Gravis
Dr Goyal discusses new and emerging mechanisms of action to treat myasthenia gravis.
Atypical Presentation of Myasthenia Gravis and Importance of Early Diagnosis
A expert discusses atypical presentation of myasthenia gravis and importance of early diagnosis and treatment.
Subgroups and Phenotypes of Myasthenia Gravis
Dr Neelam Goyal describes types of myasthenia gravis, its presentation, and differential diagnosis of myasthenia gravis.
Myasthenia Gravis and Underlying Pathophysiology
A neuromuscular disorder specialist, Dr Neelam Goyal discusses prevalence and pathophysiology of myasthenia gravis (MG).